#University of Washington

This elevated risk only applied to a certain type of heart attack, called type 2 myocardial infarction, in a recent study.

This amfAR grant hopes to find out. It’s part of $1.16 million in new funding from ARCHE.

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

In the future, women’s HIV prevention efforts may be as familiar a process as inserting a tampon, thanks to research showing that water-solubl...

With the FDA approval of Sovaldi (sofosbuvir) and Olysio (simeprevir), many people with hepatitis C, including those coinfected with HIV...

A Chinese study proves that antiretroviral therapy can indeed reduce transmissions among serodiscordant heterosexual couples.

The hepatitis C pipeline: huge changes on the horizon

Researchers found electrically spun cloth can create both a chemical and physical barrier to prevent both pregnancy and HIV transmission.

Online gamers map structure of retrovirus protein, which has baffled scientists for more than a decade, in three weeks.

A new study shows that HIV-positive women are twice as likely to transmit the virus to a sexual partner if they use hormone-based birth contro...

Viread (tenofovir) and Truvada (tenofovir plus emtricitabine), when used as pre-exposure prophylaxis (PrEP) “definitively” reduced the...

Universal testing for hepatitis C virus (HCV) infection, as opposed to testing based on known risk factors, is the way to go, according to a s...

Annual deaths of women from pregnancy and childbirth around the world have dropped significantly from about 526,300 in 1980 to 342,900 in 2008...

Treating herpes simplex 2 (HSV-2) in HIV-positive people does not reduce the risk of transmitting HIV to their sexual partners, according to s...

While national guidelines recommend that patients begin antiretroviral treatment when their CD4 count drops below 350, new research supports s...

Research suggests starting treatment with a higher CD4 count.